Family planning and multiple sclerosis – part 2: Does real-world practice align with Swedish treatment guidelines?
Alejandra Machado, Emma Pettersson, Fitsum Sebsibe Teni, Emilie Friberg, Katharina Fink · 2026
Read Family planning and multiple sclerosis – part 2: Does real-world practice align with Swedish treatment guidelines? by Alejandra Machado, Emma Pettersson, Fitsum Sebsibe Teni, Emilie Friberg, Katharina Fink (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13400928.txt.
Description
Alejandra Machado and colleagues check, in 2026, whether real-world pregnancy care for women with multiple sclerosis in Sweden matches national guidelines. Managing the disease around pregnancy means balancing disease control against drug safety for mother and fetus. Clinicians often adapt standard advice to each case.
The study linked survey responses from 130 women, covering 153 pregnancies, to the national MS register. Before conception, most cases involved drugs for which guidelines advise stopping before pregnancy. One drug, rituximab, accounted for nearly half of all cases. Many women continued treatment, or had recent treatment, around conception. After birth, over half resumed therapy. Many others delayed, likely for breastfeeding. Practice broadly aligned with national guidance, the authors conclude.
Catalog record
| CREATOR | Alejandra Machado, Emma Pettersson, Fitsum Sebsibe Teni, Emilie Friberg, Katharina Fink |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19401 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |